Azzad Asset Management’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.12M | Sell |
42,381
-3,476
| -8% | -$584K | 0.76% | 13 |
|
|
2025
Q1 | $6.32M | Sell |
45,857
-155
| -0.3% | -$21.4K | 0.74% | 19 |
|
|
2024
Q4 | $5.44M | Buy |
46,012
+1,144
| +3% | +$135K | 1.05% | 18 |
|
|
2024
Q3 | $4.96M | Buy |
44,868
+15,201
| +51% | +$1.68M | 0.56% | 37 |
|
|
2024
Q2 | $2.92M | Buy |
29,667
+21,793
| +277% | +$2.14M | 0.34% | 99 |
|
|
2024
Q1 | $881K | Buy |
+7,874
| New | +$881K | 0.1% | 231 |
|
|
2018
Q1 | – | Sell |
-3,390
| Closed | -$208K | – | 301 |
|
|
2017
Q4 | $208K | Sell |
3,390
-4,733
| -58% | -$290K | 0.07% | 273 |
|
|
2017
Q3 | $546K | Sell |
8,123
-21,007
| -72% | -$1.41M | 0.18% | 188 |
|
|
2017
Q2 | $2.27M | Buy |
29,130
+5,602
| +24% | +$437K | 0.81% | 19 |
|
|
2017
Q1 | $1.92M | Sell |
23,528
-3,132
| -12% | -$255K | 0.72% | 30 |
|
|
2016
Q4 | $1.92M | Buy |
26,660
+1,432
| +6% | +$103K | 0.79% | 29 |
|
|
2016
Q3 | $1.96M | Buy |
25,228
+143
| +0.6% | +$11.1K | 0.8% | 28 |
|
|
2016
Q2 | $1.96M | Buy |
25,085
+3,603
| +17% | +$281K | 0.83% | 24 |
|
|
2016
Q1 | $1.76M | Sell |
21,482
-4,659
| -18% | -$382K | 0.77% | 29 |
|
|
2015
Q4 | $2.33M | Buy |
26,141
+4,538
| +21% | +$405K | 1.12% | 8 |
|
|
2015
Q3 | $1.67M | Buy |
21,603
+3,086
| +17% | +$239K | 0.88% | 17 |
|
|
2015
Q2 | $1.55M | Sell |
18,517
-3,236
| -15% | -$271K | 0.78% | 20 |
|
|
2015
Q1 | $1.96M | Buy |
21,753
+5,834
| +37% | +$527K | 0.95% | 7 |
|
|
2014
Q4 | $1.29M | Buy |
15,919
+4,376
| +38% | +$353K | 0.68% | 22 |
|
|
2014
Q3 | $865K | Sell |
11,543
-1,380
| -11% | -$103K | 0.5% | 55 |
|
|
2014
Q2 | $886K | Buy |
12,923
+1,479
| +13% | +$101K | 0.53% | 51 |
|
|
2014
Q1 | $801K | Buy |
11,444
+914
| +9% | +$64K | 0.53% | 51 |
|
|
2013
Q4 | $703K | Buy |
10,530
+647
| +7% | +$43.2K | 0.51% | 65 |
|
|
2013
Q3 | $515K | Hold |
9,883
| – | – | 0.42% | 96 |
|
|
2013
Q2 | $507K | Buy |
+9,883
| New | +$507K | 0.43% | 87 |
|